Topics

sanofi-pasteur Company Profile

12:25 EST 15th November 2019 | BioPortfolio

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


News Articles [735 Associated News Articles listed on BioPortfolio]

Sanofi Pasteur Head: Global Flu Vaccination Rates 'Dangerously Low'

The head of Sanofi Pasteur tells Scrip more countries need to emulate the UK’s relatively high flu vaccination level, and...   

Sanofi Reports Strong Second Quarter Driven by Dupixent Launch and Vaccine Sales

Sanofi reported overall net sales increased by 5.5% for the second quarter, driven by Sanofi Genzyme, Sanofi Pasteur and emerging markets.

Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical...   

Sanofi Pasteur gets FDA approval for Dengvaxia vaccine to prevent dengue disease

Dengvaxia is said to be the first FDA-approved vaccine to prevent dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people aged between The post Sanofi Pasteur gets FDA approval ...

Sanofi Pasteur ends Clostridium difficile vaccine programme

Pasteur vs Possibility – the ever-changing face of the laboratory

The Pasteur Museum in Paris has preserved the laboratory equipment of Louis Pasteur, one of microbiology’s great founders. Antiquated but recognizable devices such as microscopes, Bunsen burners, an...

AbbVie Ups The Ante For Upadacitinib At EULAR

With data showing the superiority of its JAK inhibitor over Humira, the US firm is looking beyond treating the symptoms...   

Sanofi Selects Novartis Executive to Replace Retiring CEO

Brandicourt, who has helmed Sanofi since 2015, will retire from his CEO role this fall. Sanofi has a rule that its CEO cannot be over the age of 65.

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Tubersol [sanofi pasteur inc.]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Avalide [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE (irbesartan and hydrochlorothiazide) tablets, fo...

Methenamine hippurate [winthrop u.s.]

METHENAMINE HIPPURATE TABLETS, USP

Taxotere [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) injection, for intravenous use In...

Elitek [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ELITEK safely and effectively. See full prescribing information for ELITEK. ELITEK (rasburicase) for injection, for intravenous useIn...

PubMed Articles [33 Associated PubMed Articles listed on BioPortfolio]

A review of Dengvaxia®: development to deployment.

Dengue is the world's most prevalent and important arboviral disease. More than 50% of the world's population lives at daily risk of infection and it is estimated more than 95 million people a year se...

Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia.

The world's first dengue vaccine [Dengvaxia; Sanofi Pasteur] was licensed in 2015 and others are in development. Real-world evaluations of dengue vaccines will therefore soon be needed. We assessed fe...

Duclaux, Chamberland, Roux, Grancher, and Metchnikoff: the five musketeers of Louis Pasteur.

The Institut Pasteur was created thanks to worldwide generosity with the aim to welcome and treat rabies patients, to provide a place for scientific research and to offer new teaching programs in micr...

Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4-5 Years After a Primary 3-Dose Schedule.

The tetravalent dengue vaccine (CYD-TDV, Dengvaxia, Sanofi Pasteur) demonstrated efficacy in 2 previous phase III trials conducted in endemic countries. Neutralizing antibodies (NAbs) elicited by 3 do...

Reflections on Three Episodes of Louis Pasteur's Life as Seen in the William Dieterle's Movie (1936).

Despite the criticism and reservations made about him still nowadays, Louis Pasteur may be considered one of the most important scientists of the last two centuries in public health, even if the work ...

Clinical Trials [99 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Phase III, open, mono-center study in 177 infants who received a dose of Hep B vaccine at birth or within 1 month after birth. Infants will receive Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T c...

Companies [83 Associated Companies listed on BioPortfolio]

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

Sanofi Pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

sanofi-pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

sanofi pasteur S.A.

It is rare for a company's history to be so tightly interwoven with the history of a major health care discovery. Sanofi pasteur is the result of the meeting of three exceptional destinies, those of m...

March of Dimes and Sanofi Pasteur

More Information about "sanofi-pasteur" on BioPortfolio

We have published hundreds of sanofi-pasteur news stories on BioPortfolio along with dozens of sanofi-pasteur Clinical Trials and PubMed Articles about sanofi-pasteur for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of sanofi-pasteur Companies in our database. You can also find out about relevant sanofi-pasteur Drugs and Medications on this site too.

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record